Advertisement

Canadian Journal of Public Health

, Volume 96, Issue 4, pp 250–253 | Cite as

The Effect of Income on Anaphylaxis Preparation and Management Plans in Toronto Primary Schools

  • David W. Frost
  • Catherine G. ChalinEmail author
Article

Abstract

Background

Outcomes of serious allergic reactions are worse at school than at home. Prompt administration of epinephrine is the first-line treatment for anaphylactic reactions, and the EpiPen® device is not subsidized by Ontario public health insurance. This study examines the relationship between the proportion of low-income households in Toronto neighbourhoods and the adequacy of anaphylaxis management plans in primary schools.

Methods

A survey was administered to principals of primary schools. It addressed the areas of: prevalence of food allergy, the presence of EpiPen at school and staff training in its use, and exposure prevention policy. The results were correlated to 2001 Canadian Census data for percentage of low-income households in each school’s area.

Results

Children with reported severe food allergy attending schools in areas with greater than 20% low-income households were less likely to have medication at school than those in neighbourhoods with less than 20% (relative risk 2.2, 95% confidence interval 1.1–4.4). Other aspects of the anaphylaxis action plan, including staff EpiPen training and parental provision of information to the school, showed no significant correlation to income. Overall, about 50% of schools have their entire teaching staff trained to administer the EpiPen.

Interpretation

The lack of medication at school for anaphylaxis is a limiting factor in optimal anaphylaxis management in the school setting. Government support in the purchase of EpiPen in low-income households may be indicated.

MeSH terms

Anaphylaxis income children epinephrine 

Résumé

Contexte

Les conséquences des réactions allergiques graves sont plus néfastes à l’école qu’à domicile. L’administration prompte d’épinéphrine est le traitement principal en cas d’anaphylaxie. Cependant, l’auto-injecteur EpiPen® n’est pas subventionné par le régime d’assurance-maladie de l’Ontario. Nous avons examiné la relation entre la proportion de ménages à faible revenu dans des quartiers de Toronto et la qualité des plans de traitement de l’anaphylaxie dans les écoles primaires.

Méthode

Nous avons administré une enquête aux directeurs d’établissements. L’enquête a inclus des questions sur la prévalence des allergies alimentaires, la présence de l’EpiPen à l’école et la formation du personnel pour l’administrer, ainsi que les consignes pour limiter l’exposition aux allergènes. Les résultats ont été corrélés avec le pourcentage, tiré du recensement canadien de 2001, de ménages à faible revenu dans chaque quartier.

Résultats

Il était moins probable que les enfants avec une allergie grave dans des quartiers ayant plus de 20% de ménages à faible revenu aient eu d’EpiPen à l’école que ceux vivant dans les quartiers ayant moins de 20% de tels ménages (risque relatif = 2,2, intervalle de confiance de 95% = 1,1–4,4). D’autres aspects du plan d’action contre l’anaphylaxie, y compris la formation du personnel et la fourniture d’information par les parents, n’ont montré aucune corrélation significative avec le revenu. En général, tout le personnel a reçu la formation pour administrer l’EpiPen dans 50% des écoles.

Interprétation

Le manque de médicaments contre l’anaphylaxie est un facteur limitant pour le traitement de l’anaphylaxie à l’école. Il se peut qu’un soutien gouvernemental à l’achat de l’EpiPen soit nécessaire pour les ménages à faible revenu.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Salter J, Mehra S, Cairns JT, Sussman G, Vadas P. A study of 32 food-induced anaphylaxis deaths in Ontario: 1986–2000. https://doi.org/www.anaphylaxis.ca/ (accessed April, 2004).Google Scholar
  2. 2.
    Moneret-Vautrin G, Kanny G, Morisset M, Flabbee J, Guenard L, Beaudouin E, et al. Food anaphylaxis in schools: Evaluation of the management plan and the efficiency of the emergency kit. Allergy 2001;56:1071–76.CrossRefGoogle Scholar
  3. 3.
    Sampson HA, Mendelson L, Rosen JP. Fatal and near fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:280–84.CrossRefGoogle Scholar
  4. 4.
    Nowak-Wegrzyn A, Conover-Walker M, Wood RA. Food-allergic reactions in schools and preschools. Arch Pediatr Adolesc Med 2001;155:790–95.CrossRefGoogle Scholar
  5. 5.
    Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 2001;357:111–15.CrossRefGoogle Scholar
  6. 6.
    Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol 2000;106:171–76.CrossRefGoogle Scholar
  7. 7.
    Canadian Medical Association Drug Information. https://doi.org/www.cma.ca/index.cfm/ ci_id/370/la_id/1.htm/ (accessed June, 2004).
  8. 8.
    Watura JC. Nut allergy in schoolchildren: A survey of schools in the Severn NHS Trust. Arch Dis Child 2002;86:240–44.CrossRefGoogle Scholar
  9. 9.
    City of Toronto Electoral Ward Profiles. https://doi.org/www.city.toronto.on.ca/demographics/ind ex.htm/ (accessed May, 2004).
  10. 10.
    Al-Muhsen S, Clarke AE, Kagan RS. Peanut allergy: An overview. CMAJ 2003;168:1279–85.PubMedPubMedCentralGoogle Scholar

Copyright information

© The Canadian Public Health Association 2005

Authors and Affiliations

  1. 1.Department of Public Health Sciences, Faculty of MedicineUniversity of TorontoTorontoCanada

Personalised recommendations